AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Ca Finance Yahoo

Published November 13, 2026 · Updated November 14, 2026

Enveric Biosciences Reports Financial Results for Third Quarter 2026 and Provides ...

Read the full story at Ca Finance Yahoo

Contact the press release ... Supported the FDA release of finalized guidance for clinical investigations of psychedelic and psychedelic -inspired.

Post on X

Share this story

Surfaced by 2 Google Alerts

Psychedelic press release
Mescaline